Metabolic Tumour Burden Measured by (18)F-FDG PET/CT Predicts Malignant Transformation in Patients with Neurofibromatosis Type-1

BACKGROUND: To investigate the diagnostic and prognostic performances of (18)F-FDG PET/CT measures of metabolic tumour burden in patients with neurofibromatosis type-1 (NF1), suspect of malignant transformation. METHODS: This retrospective study included 49 patients (15–60 years old, 30 women) with...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:PLoS One
Auteurs principaux: Van Der Gucht, Axel, Zehou, Ouidad, Djelbani-Ahmed, Soraya, Valeyrie-Allanore, Laurence, Ortonne, Nicolas, Brugières, Pierre, Wolkenstein, Pierre, Luciani, Alain, Rahmouni, Alain, Sbidian, Emilie, Itti, Emmanuel
Format: Artigo
Langue:Inglês
Publié: Public Library of Science 2016
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4795780/
https://ncbi.nlm.nih.gov/pubmed/26987124
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0151809
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires